MAPT and Alzheimer disease: Such clearance of amyloid plaques or tau tangles has been strikingly demonstrated in animal models [165, 166] and can be detected in humans when PET tracers that bind to the protein aggregate in question are available—currently limited to amyloid and tau in AD.